Everett E. Vokes, MD
Everett E. Vokes, MD, FASCO, who is a Giants of Cancer Care®
recipient for Head and Neck Cancer, has been named the next president of ASCO for the 2021 to 2022 term.
Beyond Vokes, 4 new members were also elected to the ASCO Board of Directors and Nominating Committee, including:
- Enrique Soto Pérez de Celis, MD, Msc, who is a geriatric oncologist and researcher in the Department of Geriatrics at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City;
- Tara O. Henderson, MD, MPH, FASCO, an associate professor of pediatrics, director of the Childhood Cancer Survivor Center at the University of Chicago, and director of Survivorship for the University of Chicago Comprehensive Cancer Center;
- Lisa A. Carey, MD, FASCO, chief of Hematology/Oncology, associate director of Clinical Sciences, and the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research at the University of North Carolina Lineberger Comprehensive Cancer Center, and physician-in-chief of the NC Cancer Hospital;
- Elizabeth R. Plimack, MD, MS, chief of the Division of Genitourinary Medical Oncology, professor of medical oncology and the director of Genitourinary Clinical Research at Fox Chase Cancer Center.
Two new members have been added to the ASCO Nominating Committee and will each serve 3-year terms. These include: Beverly S. Mitchell, MD, a hematologist and oncologist, and George E. Becker Professor of Medicine at Stanford Cancer Institute; and Jordan D. Berlin, MD, FASCO, the associate director for Clinical Research, an Ingram Professor of Cancer Research, and a professor of medicine (hematology/oncology) at Vanderbilt-Ingram Cancer Center.
Everett E. Vokes, MD, FASCO, Elected ASCO President for 2021-2022 Term [news release]. American Society for Clinical Oncology. Published December 17, 2019. https://bit.ly/2Md5mHf. Accessed December 19, 2020.
... to read the full story